319 related articles for article (PubMed ID: 2839716)
1. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
Chin MT; Hirochika R; Hirochika H; Broker TR; Chow LT
J Virol; 1988 Aug; 62(8):2994-3002. PubMed ID: 2839716
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.
Chin MT; Broker TR; Chow LT
J Virol; 1989 Jul; 63(7):2967-76. PubMed ID: 2542607
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements.
Dong G; Broker TR; Chow LT
J Virol; 1994 Feb; 68(2):1115-27. PubMed ID: 8289341
[TBL] [Abstract][Full Text] [Related]
4. Functional mapping of the human papillomavirus type 11 transcriptional enhancer and its interaction with the trans-acting E2 proteins.
Hirochika H; Hirochika R; Broker TR; Chow LT
Genes Dev; 1988 Jan; 2(1):54-67. PubMed ID: 2833426
[TBL] [Abstract][Full Text] [Related]
5. The human papillomavirus type 18 (HPV18) E2 gene product is a repressor of the HPV18 regulatory region in human keratinocytes.
Bernard BA; Bailly C; Lenoir MC; Darmon M; Thierry F; Yaniv M
J Virol; 1989 Oct; 63(10):4317-24. PubMed ID: 2476572
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product.
Phelps WC; Howley PM
J Virol; 1987 May; 61(5):1630-8. PubMed ID: 3033289
[TBL] [Abstract][Full Text] [Related]
7. An E1M--E2C fusion protein encoded by human papillomavirus type 11 is asequence-specific transcription repressor.
Chiang CM; Broker TR; Chow LT
J Virol; 1991 Jun; 65(6):3317-29. PubMed ID: 1851879
[TBL] [Abstract][Full Text] [Related]
8. The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region.
Thierry F; Yaniv M
EMBO J; 1987 Nov; 6(11):3391-7. PubMed ID: 2828029
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.
Cripe TP; Haugen TH; Turk JP; Tabatabai F; Schmid PG; Dürst M; Gissmann L; Roman A; Turek LP
EMBO J; 1987 Dec; 6(12):3745-53. PubMed ID: 2448139
[TBL] [Abstract][Full Text] [Related]
10. Enhancers and trans-acting E2 transcriptional factors of papillomaviruses.
Hirochika H; Broker TR; Chow LT
J Virol; 1987 Aug; 61(8):2599-606. PubMed ID: 3037119
[TBL] [Abstract][Full Text] [Related]
11. Control of human papillomavirus type 11 origin of replication by the E2 family of transcription regulatory proteins.
Chiang CM; Dong G; Broker TR; Chow LT
J Virol; 1992 Sep; 66(9):5224-31. PubMed ID: 1323690
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of E2-mediated repression of the HPV18 P105 promoter.
Thierry F; Howley PM
New Biol; 1991 Jan; 3(1):90-100. PubMed ID: 1645591
[TBL] [Abstract][Full Text] [Related]
13. The functional BPV-1 E2 trans-activating protein can act as a repressor by preventing formation of the initiation complex.
Dostatni N; Lambert PF; Sousa R; Ham J; Howley PM; Yaniv M
Genes Dev; 1991 Sep; 5(9):1657-71. PubMed ID: 1653173
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells.
Ishiji T; Lace MJ; Parkkinen S; Anderson RD; Haugen TH; Cripe TP; Xiao JH; Davidson I; Chambon P; Turek LP
EMBO J; 1992 Jun; 11(6):2271-81. PubMed ID: 1318197
[TBL] [Abstract][Full Text] [Related]
15. Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.
Rapp B; Pawellek A; Kraetzer F; Schaefer M; May C; Purdie K; Grassmann K; Iftner T
J Virol; 1997 Sep; 71(9):6956-66. PubMed ID: 9261424
[TBL] [Abstract][Full Text] [Related]
16. Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.
Stünkel W; Huang Z; Tan SH; O'Connor MJ; Bernard HU
J Virol; 2000 Mar; 74(6):2489-501. PubMed ID: 10684263
[TBL] [Abstract][Full Text] [Related]
17. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
18. A bovine papillomavirus constitutive enhancer is negatively regulated by the E2 repressor through competitive binding for a cellular factor.
Vande Pol SB; Howley PM
J Virol; 1990 Nov; 64(11):5420-9. PubMed ID: 2170679
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region.
Butz K; Hoppe-Seyler F
J Virol; 1993 Nov; 67(11):6476-86. PubMed ID: 8411351
[TBL] [Abstract][Full Text] [Related]
20. The specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancer.
Hawley-Nelson P; Androphy EJ; Lowy DR; Schiller JT
EMBO J; 1988 Feb; 7(2):525-31. PubMed ID: 2835231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
